Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication

被引:23
作者
Taskin, Orhun Cig [1 ]
Clarke, Callisia N. [2 ]
Erkan, Mert [3 ,4 ]
Tsai, Susan [2 ]
Evans, Douglas B. [2 ]
Adsay, Volkan [1 ]
机构
[1] Koc Univ Hosp, Dept Pathol, Davutpasa Caddesi 4, TR-34010 Istanbul, Turkey
[2] Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA
[3] Koc Univ Hosp, Dept Surg, Istanbul, Turkey
[4] Koc Univ, Res Ctr Translat Med, Istanbul, Turkey
关键词
Pancreas; neuroendocrine neoplasm; tumor; carcinoma; pathology; terminology; classification; prognosis; WHO; 2019; KI67 PROLIFERATIVE INDEX; CLINICOPATHOLOGICAL ANALYSIS; ENDOCRINE NEOPLASMS; HIGH-GRADE; GASTROENTEROPANCREATIC SYSTEM; CONSENSUS GUIDELINES; LABELING INDEX; CELL-CARCINOMA; TUMORS; EXPRESSION;
D O I
10.21037/jgo.2020.03.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Significant improvements have taken place in our understanding of classification neuroendocrine neoplasms of the pancreas in the past decade. "These are now regarded in three entirely separate categories: (I) neuroendocrine tumors (PanNETs) are by definition well differentiated, the pancreatic counterpart of carcinoids; (II) neuroendocrine carcinomas, which are poorly differentiated (PDNEC), the pancreatic examples of small cell carcinomas or large cell neuroendocrine carcinomas; (III) other neoplasms that have neuroendocrine differentiation or a distinct neuroendocrine component. PanNETs are by far the most common. They are now regarded as malignancies (albeit often curable when low grade and low stage) with the exception of minute incidental proliferations (tumorlets, or dysplastic-like changes) seen in the setting of some syndromes like MEN. PanNETs are staged based on their size, and for small T1 tumors, watchful waiting is now being considered, although these tumors are also known to show about 10% metastatic rate and/or progression, creating concerns about this approach. PanNETs are graded into 3, based on the proliferative activity, mostly based on the Ki-67 index, and also partly mitotic activity, although the latter seldom if ever is the determinant of the final grade. Neuroendocrine neoplasms with well differentiated morphology but Ki-67 >20% are now regarded as Pa.nNFT Grade 3 (G3); they have been shown to have a prognosis significantly worse than lesser grade PanNETs but still incomparably better than frank PDNECs, the latter typically has Ki-67 >50% (often much higher) and require platinum-based chemotherapy. There are also cases that are ambiguous between PanNET-G3 and PDNEC, and very rarely transformation of the former to the latter appears to occur. For low grade (G 1/G2) PanNETs, more refined criteria to further prognosticate this group are needed. Morphologic variants being recognized may bring new perspectives to this group.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 68 条
[1]   Ki67 Labeling Index in Neuroendocrine Tumors of the Gastrointestinal and Pancreatobiliary Tract To Count or Not to Count Is Not the Question, But Rather How to Count [J].
Adsay, Volkan .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) :1743-1746
[2]   Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1:: Criteria, molecular concepts and clinical significance [J].
Anlauf, Martin ;
Perren, Aurel ;
Kloeppel, Guenter .
PATHOBIOLOGY, 2007, 74 (05) :279-284
[3]   Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database [J].
Assi, Hussein A. ;
Mukherjee, Sarbajit ;
Kunz, Pamela L. ;
Machiorlatti, Michael ;
Vesely, Sara ;
Pareek, Vipul ;
Hatoum, Hassan .
ONCOLOGIST, 2020, 25 (02) :E276-E283
[4]   The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms [J].
Basturk, Olca ;
Yang, Zhaohai ;
Tang, Laura H. ;
Hruban, Ralph H. ;
Adsay, Volkan ;
McCall, Chad M. ;
Krasinskas, Alyssa M. ;
Jang, Kee-Taek ;
Frankel, Wendy L. ;
Balci, Serdar ;
Sigel, Carlie ;
Klimstra, David S. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (05) :683-690
[5]   Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases [J].
Basturk, Olca ;
Tang, Laura ;
Hruban, Ralph H. ;
Adsay, Volkan ;
Yang, Zhaohai ;
Krasinskas, Alyssa M. ;
Vakiani, Efsevia ;
La Rosa, Stefano ;
Jang, Kee-Taek ;
Frankel, Wendy L. ;
Liu, Xiuli ;
Zhang, Lizhi ;
Giordano, Thomas J. ;
Bellizzi, Andrew M. ;
Chen, Jey-Hsin ;
Shi, Chanjuan ;
Allen, Peter ;
Reidy, Diane L. ;
Wolfgang, Christopher L. ;
Saka, Burcu ;
Rezaee, Neda ;
Deshpande, Vikram ;
Klimstra, David S. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (04) :437-447
[6]  
CAP, 2019, COLL AM PATH CANC PR
[7]   ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup [J].
Chan, Chang S. ;
Laddha, Saurabh, V ;
Lewis, Peter W. ;
Koletsky, Matthew S. ;
Robzyk, Kenneth ;
Da Silva, Edaise ;
Torres, Paula J. ;
Untch, Brian R. ;
Li, Janet ;
Bose, Promita ;
Chan, Timothy A. ;
Klimstra, David S. ;
Allis, C. David ;
Tang, Laura H. .
NATURE COMMUNICATIONS, 2018, 9
[8]   Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified? [J].
Ferrone, Cristina R. ;
Tang, Laura H. ;
Tomlinson, James ;
Gonen, Mithat ;
Hochwald, Steven N. ;
Brennan, Murray F. ;
Klimstra, David S. ;
Allen, Peter J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) :5609-5615
[9]   A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms [J].
Gao, Yong ;
Gao, Hao ;
Wang, Guangfu ;
Yin, Lingdi ;
Xu, Wenbin ;
Peng, Yunpeng ;
Wu, Junli ;
Jiang, Kuirong ;
Miao, Yi .
SCIENTIFIC REPORTS, 2018, 8
[10]   Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas:: incidence, types, biological behavior, association with inherited syndromes, and functional activity [J].
Garbrecht, Nele ;
Anlauf, Martin ;
Schmitt, Anja ;
Henopp, Tobias ;
Sipos, Bence ;
Raffel, Andreas ;
Eisenberger, Claus F. ;
Khoefel, Wolfram T. ;
Pavel, Marianne ;
Fottner, Christian ;
Musholt, Thomas J. ;
Rinke, Anja ;
Arnold, Rudolf ;
Berndt, Uta ;
Ploeckinger, Ursula ;
Wiedenmann, Bertram ;
Moch, Holger ;
Heitz, Philipp U. ;
Komminoth, Paul ;
Perren, Aurel ;
Kloeppel, Guenter .
ENDOCRINE-RELATED CANCER, 2008, 15 (01) :229-241